Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
1,274 total articles
Ambow Education Holding Ltd. (NYSE American: AMBO), a leader in AI-powered phygital education and collaboration solutions, announced it will host an exclusive Open House to demonstrate its patented HybriU platform during the ASU+GSV 2026 conference. The event offers hands-on experience with its immersive 3D and AI-driven platform that bridges physi…
YY Group Holding Limited has paused its At-The-Market (ATM) equity offering program after determining it has adequate liquidity to meet near-term operational needs and revenue guidance for fiscal year 2026. The company will cancel over one million allocated shares and does not plan to issue more shares under the program at this time. The move refle…
Eva Live Inc., a Nasdaq-listed AI-driven digital advertising company, has engaged law firm Anderson Kill P.C. to implement a strategy aligning with Nasdaq's new tokenization framework. This initiative aims to prepare GOAI for tokenized securities trading, enhancing liquidity, global investor access, and faster settlement cycles through blockchain t…
Turbo Energy S.A. expects to report unaudited revenues of $22.5-$23.5 million for fiscal year 2025, reflecting 130%-140% year-over-year growth. This growth highlights the company's successful transformation from a product-focused solar storage provider to an AI-driven intelligent energy integrator. Turbo Energy is expanding in commercial & industri…
Giftify, Inc., operating CardCash.com, announced a 14.2% year-over-year increase in sell-side order volume and an 18.5% rise in new seller acquisition for the period January 1 through March 15, 2026. These growth metrics reflect the expanding supply base of gift cards ahead of the spring buying season, driven by targeted digital marketing initiativ…
Scienture Holdings, Inc. reported a significant 216% revenue increase for 2025 driven by the successful launch of Arbli™, the first FDA-approved oral liquid losartan formulation. Gross margin improved dramatically to 76.8% with enhanced commercial coverage secured through multiple GPO and health plan agreements, positioning the company for continue…
Kaltura announced a strategic partnership with Descript to combine their AI-powered video and audio editing tools. The alliance aims to help enterprises, especially in regulated industries like healthcare, to efficiently scale video content production while maintaining compliance and human oversight. The partnership already secured a commercial cus…
Westwood Holdings Group celebrates the 25th anniversary of its Westwood Real Estate Income Fund, highlighting a legacy of disciplined investing, consistent income generation, and active management of publicly-traded real estate securities, including a focus on preferred securities issued by REITs. The fund continues to invest across both traditiona…
Esperion Therapeutics announced new data from the CLEAR Outcomes clinical trial demonstrating that their drug bempedoic acid (marketed as NEXLETOL and NEXLIZET) reduces the risk of ischemic stroke by 22% compared to placebo in statin-intolerant patients and provides cardiovascular benefits in patients with autoimmune or inflammatory diseases. These…
SEALSQ Corp., a developer of post-quantum cryptography and PKI hardware and software, has joined the ECHONET Consortium to provide its INeS PKI platform services, aiming to improve identity, authentication, and security of smart home and energy devices in Japan. This partnership supports ECHONET's security framework with scalable, secure device aut…
Tokyo Lifestyle Co., Ltd. (Nasdaq: TKLF) has entered a three-year strategic cooperation agreement with BrainAurora Medical Technology Limited (6681.HK) to develop an integrated platform combining BrainAurora's digital cognitive impairment therapies with Tokyo Lifestyle’s functional health products. The partnership aims to address the growing elderl…
JE Cleantech Holdings Limited announced that its subsidiary, JCS-Echigo Pte Ltd, secured approximately $12 million in new orders for precision cleaning systems from an existing customer in Q1 2026, with deliveries expected over the next year. The company plans to leverage longstanding customer relationships, expand its product portfolio, and enhanc…
Lianhe Sowell International Group Ltd., listed on Nasdaq as LHSW, has entered a $1.8 million contract with California-based HECA Group to develop an AI-driven steam car-wash robot. The innovative robot aims to significantly reduce water consumption in car washes by up to 90% compared to conventional systems and eliminate chemical foam usage. This p…
Eikon Therapeutics closed an upsized IPO in February 2026 raising $381 million, strengthening its balance sheet to advance multiple late-stage clinical programs primarily in oncology. Key trial enrollments completed in non-small cell lung cancer and progress continued for selective PARP1 inhibitors and a novel WRN helicase inhibitor. The company re…
WISeKey's subsidiary WISeSat.Space successfully launched its 21st satellite equipped with SEALSQ's post-quantum QS7001 chip into Low Earth Orbit via SpaceX's Transporter-16 rideshare mission. This launch marks a significant advancement in WISeKey's vision to deliver quantum-secure, high-speed broadband connectivity through a growing constellation o…
InflaRx N.V. reported Phase 3 clinical data for vilobelimab in pyoderma gangrenosum (PG) featured at the 2026 American Academy of Dermatology Annual Meeting. The study was terminated early for futility but showed promising trends in clinical remission and ulcer healing compared to placebo, alongside a favorable safety profile. InflaRx plans to enga…
Can-Fite BioPharma announced that its veterinary partner Vetbiolix has completed enrollment in a Phase 2 clinical trial testing Piclidenoson for osteoarthritis in dogs. Data is expected in Q3 2026. Vetbiolix has exercised its option to fully license Piclidenoson for veterinary use, with Can-Fite eligible for up to $325 million in payments subject t…
Unicycive Therapeutics announced its full year 2025 financial results and provided a business update highlighting the FDA's acceptance of the New Drug Application resubmission for oxylanthanum carbonate (OLC), an investigational treatment for hyperphosphatemia in patients with chronic kidney disease on dialysis. The FDA has set a PDUFA target actio…
CareCloud, Inc. announced the successful conversion of its Series A Preferred Stock into common equity, increasing outstanding common shares substantially. The company reported stable stock performance since the conversion and reaffirmed its financial guidance and growth prospects. Despite a contained cybersecurity incident affecting one of its EHR…
USA Rare Earth, Inc. reported its financial and operational results for 2025, highlighting key strategic acquisitions, a $1.5 billion capital raise, expected $1.6 billion U.S. government funding, and accelerated plans to develop a fully integrated rare earth supply chain in the U.S., UK, and Europe. The company advanced its hydrometallurgical facil…
Hope Therapeutics, a subsidiary of NRx Pharmaceuticals (Nasdaq: NRXP), announced a strategic partnership with Emobot Health to deploy its AI-driven 'Depression Thermometer' across a network of interventional psychiatry clinics. This passive monitoring tool uses AI to analyze facial expressions, vocal tones, and activity data via smartphones to dete…
Oatly Group AB, the leading oat-based beverage company, will release its financial results for Q1 ending March 31, 2026, on April 29, 2026, prior to the U.S. market open. A conference call and webcast will be held to discuss the results. Oatly continues to lead in the plant-based dairy alternative sector with a wide portfolio available in over 50 c…
Ellomay Capital Ltd. has agreed to sell its indirect 33.75% stake in Dorad Energy Ltd. through Ellomay Luzon Energy Infrastructures Ltd. to Amos Luzon Development and Energy Group Ltd. for approximately NIS 560 million, based on a Dorad valuation of NIS 4.4 billion. The transaction is subject to regulatory approvals and customary closing conditions…
Reviva Pharmaceuticals reports 2025 financial results showing reduced net loss and $23 million cash post equity offerings. The FDA has recommended a second Phase 3 clinical trial for brilaroxazine in schizophrenia before NDA submission. The company plans to initiate the RECOVER-2 registrational trial mid-2026, supported by a comprehensive clinical …
DHT Holdings, Inc. announced the delivery of the DHT Gazelle, a new Very Large Crude Carrier (VLCC), continuing its fleet modernization program. The new vessel will start a long-term time charter with a major oil company, and the company has completed the sale of two older vessels as part of its fleet renewal strategy. These moves are aimed at impr…
